Cytogenetic profile of chronic myeloid leukemias.
Jacob, Rachel Thomas; Gayathri, K; Surath, Anjna; Rao, D Raghunadha.
Indian J Cancer
; 2002 Jun; 39(2): 61-5
Artículo en Inglés | IMSEAR | ID: sea-49645
Documentos relacionados
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.
Characterisation of clonal Philadelphia-negative cytogenetic abnormalities in a large cohort of chronic myeloid leukaemia.
[BCR-ABL1 negative chronic myeloid leukemia: report of two cases].
How I treat atypical chronic myeloid leukemia.
Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
Hydroxyurea- a cost effective treatment in developing countries for Atypical Chronic Myeloid Leukemia (aCML): Case Report of Two Patients.
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
Atypical CML: diagnosis and treatment.
Atypical Chronic Myeloid Leukemia: Where Are We Now?